The effect of exemestane on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer
Not Applicable
Completed
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000020499
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 81
Inclusion Criteria
Not provided
Exclusion Criteria
Patients already treated as osteoporosis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BMD change from baseline to 5 years at the lumbar spine and femoral neck
- Secondary Outcome Measures
Name Time Method BMD change from baseline to 6, 12, 24, 36, 48, and 72 months at the lumbar spine and femoral neck Bone fracture rate during 5 years